INS and type 2 diabetes mellitus: For example, the addition of nicotinamide protects pancreatic β cells from the cytotoxicity of alloxan or STZ, while still allowing the manifestation of key T2DM features such as impaired insulin secretion, β cell fatigue, and a decline in β cell mass (112–114).